We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SL Green Allots Additional Space to The Carlyle Group at NYC
Read MoreHide Full Article
Recently, SL Green Realty Corp. (SLG - Free Report) extended its 15-year lease with The Carlyle Group (CG - Free Report) at its New York City property — One Vanderbilt. Per the extension, the global investment firm will now occupy an additional 32,592-square-foot space on the entire 35th floor of the office tower.
With this lease’s expansion, The Carlyle Group will now own 127,744 square feet of space across floors 35 through 38 on the 1,401-foot East Midtown property. This trophy tower, which has reached the 73rd floor since its ground breaking in 2016, is slated for an opening in 2020.
SL Green is likely to witness decent demand for space at this property for its superior positioning and amenities. In fact, One Vanderbilt is anticipated to achieve both LEED Gold under version 4.0 and WELL certifications. It will cater several amenities to its tenants, including a 30,000-square-foot tenant-only amenity floor, with large format meeting spaces, a club-style lounge and an outdoor terrace.
This apart, the property also enjoys proximity to the Grand Central Terminal, giving it easy access to the nearest transit network. SL Green plans to invest $220 million in private funds in a bid to augment this transit system.
Apart from The Carlyle Group, a number of reputed firms from the financial, banking and legal industries have entered into lease deals for occupying space in this property. Some of its tenants include TD Securities, a leading banking and investment group, MFA Financial (MFA - Free Report) , a publicly-traded real estate investment trust, as well as law firm Greenberg Traurig, and German financial firms DZ and DVB Banks.
Notably, SL Green possesses premium office properties and a varied tenant base, along with a solid balance sheet. Further, the company is divesting its non-core assets, and using the proceeds to fund share buybacks and development projects. However, intense competition from other market players limits the company’s pricing power.
Lamar Advertising Company (LAMR - Free Report) sports a Zacks Rank #1 (Strong Buy), at present. Its FFO per share estimates for 2019 have been revised slightly north over the past seven days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
SL Green Allots Additional Space to The Carlyle Group at NYC
Recently, SL Green Realty Corp. (SLG - Free Report) extended its 15-year lease with The Carlyle Group (CG - Free Report) at its New York City property — One Vanderbilt. Per the extension, the global investment firm will now occupy an additional 32,592-square-foot space on the entire 35th floor of the office tower.
With this lease’s expansion, The Carlyle Group will now own 127,744 square feet of space across floors 35 through 38 on the 1,401-foot East Midtown property. This trophy tower, which has reached the 73rd floor since its ground breaking in 2016, is slated for an opening in 2020.
SL Green is likely to witness decent demand for space at this property for its superior positioning and amenities. In fact, One Vanderbilt is anticipated to achieve both LEED Gold under version 4.0 and WELL certifications. It will cater several amenities to its tenants, including a 30,000-square-foot tenant-only amenity floor, with large format meeting spaces, a club-style lounge and an outdoor terrace.
This apart, the property also enjoys proximity to the Grand Central Terminal, giving it easy access to the nearest transit network. SL Green plans to invest $220 million in private funds in a bid to augment this transit system.
Apart from The Carlyle Group, a number of reputed firms from the financial, banking and legal industries have entered into lease deals for occupying space in this property. Some of its tenants include TD Securities, a leading banking and investment group, MFA Financial (MFA - Free Report) , a publicly-traded real estate investment trust, as well as law firm Greenberg Traurig, and German financial firms DZ and DVB Banks.
Notably, SL Green possesses premium office properties and a varied tenant base, along with a solid balance sheet. Further, the company is divesting its non-core assets, and using the proceeds to fund share buybacks and development projects. However, intense competition from other market players limits the company’s pricing power.
SL Green currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.
Stock to Consider
Lamar Advertising Company (LAMR - Free Report) sports a Zacks Rank #1 (Strong Buy), at present. Its FFO per share estimates for 2019 have been revised slightly north over the past seven days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>